Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomarkers predictive of cytokine release syndrome

Biomarkers predictive of cytokine release syndrome

US Patent 11747346 · Granted Sep 5, 2023

Estimated economic value: $68,729,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric a2025
Methods for improving the efficacy and expansion of immune cells2025
Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against 2025
Methods and composition for gene delivery using an engineered viral particle2024
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 bin2024
Methods for improving the efficacy and expansion of chimeric antigen receptor-ex2024
Compositions and methods of phospholipase A2 receptor chimeric autoantibody rece2024
Method of treating cancer by administering immune effector cells expressing a ch2024
Methods and compositions for gene editing in hematopoietic stem cells2023
Methods and composition for gene delivery using an engineered viral particle2023
Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against 2023
Treatment of cancer using a CD123 chimeric antigen receptor2023